![John Landis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Landis
Direktor/Vorstandsmitglied bei
EYEPOINT, INC.
Vermögen: 290 612 $ am 31.05.2026
Profil
John Barry Landis is currently Director at EyePoint, Inc. since 2018, a Member of the Chemistry Leadership Council at Purdue University, and President of Exelead, Inc. Former positions include Chairman at Inotiv, Inc. from 2011 to 2017, Director roles at Immunomedics, Inc., NanoMed Pharmaceuticals, Inc., Metabolic Solutions Development Co. LLC, Servier Symphogen A, Morrill Motors, Inc., and Pharmacia & Upjohn, Inc., Vice President at Pharmacia & Upjohn, Inc., Senior Vice President-Pharmaceutical Sciences at Schering-Plough Corp.
in 2008, Senior Vice President-Preclinical Development at The Upjohn Co. and Pharmacia Corp., and Advisory Board member at Southwest Michigan First (Venture Capital).
Education includes undergraduate studies at Kent State University (Ohio) and graduate and doctorate degrees from Purdue University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
EYEPOINT, INC. 0,03 % | 21.04.2026 | 21.400 ( 0,03 % ) | 290 612 $ | 31.05.2026 |
Aktive Positionen von John Landis
| Unternehmen | Position | Beginn |
|---|---|---|
| EYEPOINT, INC. | Direktor/Vorstandsmitglied | 25.10.2018 |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Exelead, Inc.
 Exelead, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical contract development and manufacturing company | Präsident | - |
Ehemalige bekannte Positionen von John Landis
| Unternehmen | Position | Ende |
|---|---|---|
| INOTIV, INC. | Vorsitzender | 01.01.2017 |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | 01.10.2008 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01.01.2003 |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Corporate Officer/Principal | - |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Direktor/Vorstandsmitglied | - |
Ausbildung von John Landis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Pharmacia & Upjohn, Inc.
Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
The Upjohn Co.
 The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Inotiv, Inc.
 Inotiv, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
NanoMed Pharmaceuticals, Inc.
 NanoMed Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic products | Commercial Services |
Metabolic Solutions Development Co. LLC
 Metabolic Solutions Development Co. LLC Pharmaceuticals: GenericHealth Technology Operates as a drug discovery and development company | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
EyePoint Pharmaceuticals, Inc.
 EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
Kent State University (Ohio)
 Kent State University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Morrill Motors, Inc.
 Morrill Motors, Inc. Electrical ProductsProducer Manufacturing Manufactures electric motors | Producer Manufacturing |
Southwest Michigan First (Venture Capital)
 Southwest Michigan First (Venture Capital) Investment ManagersFinance The Southwest Michigan First Life Science Fund invests exclusively in early-stage life science companies that have a presence in the Kalamazoo, Michigan region or are committed to establishing a presence in the region. The fund provides equity capital, as well as support services in the areas of industry expertise, regulatory strategy, reimbursement planning, exit strategies and early-stage business systems. | Finance |
Exelead, Inc.
Exelead, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical contract development and manufacturing company | Health Technology |
Wählen Sie MarketScreener 
